Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database

Jennifer R. Brown; Paolo Ghia; Wojciech Jurczak; Brad S. Kahl; Nicole Lamanna; Tadeusz Robak; Mazyar Shadman; Constantine S. Tam; Lugui Qiu; Jason Paik; Tommi Salmi; Liping Wang; Jun Zhang; Meng Zhang; Aileen Cohen; Han Ma; Alessandra Tedeschi

doi:10.3324/haematol.2023.283846

Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database

Jennifer R. Brown, Paolo Ghia, Wojciech Jurczak, Brad S. Kahl, Nicole Lamanna, Tadeusz Robak, Mazyar Shadman, Constantine S. Tam, Lugui Qiu, Jason Paik, Tommi Salmi, Liping Wang, Jun Zhang, Meng Zhang, Aileen Cohen, Han Ma, Alessandra Tedeschi

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	2277-2283
Number of pages	7
Journal	Haematologica
Volume	109
Issue number	7
DOIs	https://doi.org/10.3324/haematol.2023.283846
State	Published - Jul 2024

Access to Document

10.3324/haematol.2023.283846

Cite this

Brown, J. R., Ghia, P., Jurczak, W., Kahl, B. S., Lamanna, N., Robak, T., Shadman, M., Tam, C. S., Qiu, L., Paik, J., Salmi, T., Wang, L., Zhang, J., Zhang, M., Cohen, A., Ma, H., & Tedeschi, A. (2024). Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database. Haematologica, 109(7), 2277-2283. https://doi.org/10.3324/haematol.2023.283846

@article{93f8cd4d4552404296285e30bb1ed384,

title = "Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database",

author = "Brown, {Jennifer R.} and Paolo Ghia and Wojciech Jurczak and Kahl, {Brad S.} and Nicole Lamanna and Tadeusz Robak and Mazyar Shadman and Tam, {Constantine S.} and Lugui Qiu and Jason Paik and Tommi Salmi and Liping Wang and Jun Zhang and Meng Zhang and Aileen Cohen and Han Ma and Alessandra Tedeschi",

year = "2024",

month = jul,

doi = "10.3324/haematol.2023.283846",

language = "English",

volume = "109",

pages = "2277--2283",

journal = "Haematologica",

issn = "0390-6078",

number = "7",

}

Brown, JR, Ghia, P, Jurczak, W, Kahl, BS, Lamanna, N, Robak, T, Shadman, M, Tam, CS, Qiu, L, Paik, J, Salmi, T, Wang, L, Zhang, J, Zhang, M, Cohen, A, Ma, H & Tedeschi, A 2024, 'Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database', Haematologica, vol. 109, no. 7, pp. 2277-2283. https://doi.org/10.3324/haematol.2023.283846

Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database. / Brown, Jennifer R.; Ghia, Paolo; Jurczak, Wojciech et al.
In: Haematologica, Vol. 109, No. 7, 07.2024, p. 2277-2283.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies

T2 - post hoc analysis of a large clinical trial safety database

AU - Brown, Jennifer R.

AU - Ghia, Paolo

AU - Jurczak, Wojciech

AU - Kahl, Brad S.

AU - Lamanna, Nicole

AU - Robak, Tadeusz

AU - Shadman, Mazyar

AU - Tam, Constantine S.

AU - Qiu, Lugui

AU - Paik, Jason

AU - Salmi, Tommi

AU - Wang, Liping

AU - Zhang, Jun

AU - Zhang, Meng

AU - Cohen, Aileen

AU - Ma, Han

AU - Tedeschi, Alessandra

PY - 2024/7

Y1 - 2024/7

UR - http://www.scopus.com/inward/record.url?scp=85197595879&partnerID=8YFLogxK

U2 - 10.3324/haematol.2023.283846

DO - 10.3324/haematol.2023.283846

M3 - Letter

C2 - 38426293

AN - SCOPUS:85197595879

SN - 0390-6078

VL - 109

SP - 2277

EP - 2283

JO - Haematologica

JF - Haematologica

IS - 7

ER -

Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database

Access to Document

Other files and links

Cite this